Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 2/2019

01-02-2019 | Echocardiography | Echocardiography (JM Gardin and AH Waller, Section Editors)

Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging

Authors: Dalia Di Nunzio, Antonino Recupero, Cesare de Gregorio, Concetta Zito, Scipione Carerj, Gianluca Di Bella

Published in: Current Cardiology Reports | Issue 2/2019

Login to get access

Abstract

Purpose of Review

The aim is to provide a description of the most important echocardiographic features in systemic amyloidosis.

Recent Findings

Amyloidosis is a heterogeneous group of multisystem disorders, characterized by an extracellular deposition of amyloid fibrils. Several imaging tests are available for the diagnosis; however, echocardiography is the cornerstone of the non-invasive imaging modality for cardiac amyloidosis. So far, little is known about the diagnosis of cardiac amyloidosis through imaging modalities.

Summary

We summarized the most important echocardiographic findings in cardiac amyloidosis. Hence, we offered a systematic report of the diagnostic performance of cardiac amyloidosis using echocardiography.
Literature
1.
Primer on the rheumatic diseases. In JohnH. Klippel, John H. Stone, L Eslie J. Crofford, Patience H. White. Patience H. White, editors. 28th chapter. Springer-Verlag New York. 2008
2.
Mazzeo A, Russo M, Di Bella G, Minutoli F, Stancanelli C, Gentile L, et al. Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an Italian endemic area. J Neuromuscul Dis. 2015;2(s2):S39–48.CrossRef
3.
Russo M, Mazzeo A, Stancanelli C, Di Leo R, Gentile L, Di Bella G, et al. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. J Peripher Nerv Syst. 2012;17(4):385–90.CrossRef
4.
Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012;1:e000364 originally published April 23, 2012.CrossRef
5.
Flodrova P, Flodr P, Pika T, Vymetal J, Holub D, Dzubak P, et al. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Pathology. 2018 Apr;50(3):261–8.CrossRef
6.
Knight DS,Zumbo G, Barcella W, Steeden JA, Muthurangu V, Martinez-Naharro A, Treibel TA, Abdel-Gadir, et al. Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles. JACC Cardiovasc Imaging. 2018.
7.
Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013;106(10):528–40.CrossRef
8.
Kotecha T, Martinez-Naharro A, Treibel TA, Francis R, Nordin S, Abdel-Gadir A, et al. Myocardial edema and prognosis in amyloidosis. J Am Coll Cardiol. 2018;71(25):2919–31.CrossRef
9.
• Stancanelli C, Gentile L, Di Bella G, Minutoli F, Russo M, Vita G, et al. Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart. Neurol Sci. 2017;38(3):525–6 This study shows some phenotypical features of TTR amyloidosis. CrossRef
10.
•• Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120:1203–12 This study provides a global description of systemic cardiac amyloidosis. CrossRef
11.
Mesquita ET, Jorge AJL, Junior CVS, de Andrade TR. Cardiac amyloidosis and its new clinical phenotype: heart failure with preserved ejection fraction. Arq Bras Cardiol. 2017;109(1):71–80.PubMedPubMedCentral
12.
Ruberg FL. Cardiac amyloidosis: a zebra hiding in plain sight? Circ Cardiovasc Imaging. 2017;10:e006186.CrossRef
13.
•• Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Greulich S, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51(10):1022–30 This study is important because shows the diagnostic power of cardiac magnetic resonance in amyloidosis. CrossRef
14.
• Di Bella G, Minutoli F, Mazzeo A, Vita G, Oreto G, Carerj S, et al. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol. 2010;195:W394–9 This study demonstrates the diagnostic importance of MRI in cardiac amyloidosis. CrossRef
15.
• Minutoli F, Di Bella G, Mazzeo A, Donato R, Russo M, Scribano E, et al. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol. 2013;200(3):W256–65 The study provides a view of two diagnostic tools in cardiac amyloidosis. CrossRef
16.
Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54.CrossRef
17.
Jason N. Dungu, Oswaldo Valencia, Jennifer H. Pinney, Simon D.J. Gibbs, Dorota Rowczenio, Janet A. Gilbertson, Helen J. Lachmann, et al. CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis. JACC: Cardiovascular Imaging. 2014;7(2):133–142).
18.
Minutoli F, Di Bella G, Sindoni A, Vita G, Baldari S. Effectiveness of skeletal scintigraphy in transthyretin-related amyloidosis. Int J Cardiol. 2013;168(5):4988–9.CrossRef
19.
•• Bokhari S, Castanõ A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m) Tcpyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195–201 This study provides the way for differentiating the various types of amyloidosis. CrossRef
20.
Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99mTc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosis. Circ Cardiovasc Imaging. 2013;6(2):195–201.CrossRef
21.
• Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014;129:1840–9 This study provides a differentiation of two types of Cardiac Amyloidosis. CrossRef
22.
23.
Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation. 1981;63:188–96.CrossRef
24.
•• Di Bella G, Pizzino F, Minutoli F, Zito C, Donato R, Dattilo G, et al. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Eur Heart J Cardiovasc Imaging. 2014;15(12):1307–15 The review depicts the changes in cardiac imaging among the different stages of the disease. CrossRef
25.
Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived frompulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004;17:36–44.CrossRef
26.
Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446–52.CrossRef
27.
Bellavia D, Pellikka PA, Abraham TP, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101:1039–45.CrossRef
28.
Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Usefulness of combining electrocardiographic and echocardiographic findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation. Am J Cardiol. 2015;116(7):1122–7.CrossRef
29.
• Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol. 1982;49(1):9–13 The review explains the differences in the structure of the left ventricular hypertrophy.CrossRef
30.
•• Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr. 2015;13(3):84–9 This is a complete review of the diagnostic power of echocardiography in amyloidosis.CrossRef
31.
•• Koyama J, Ray-Sequin PA, Falk RH. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation. 2002;106(5):556–61 This study demonstrates that myocardial tissue plays a diagnostic and prognostic role in cardiac amyloidosis.CrossRef
32.
• Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol. 1996;28(3):658–64 This is one of the most complete study about the diastolic disfunction in cardiac amyloidosis. CrossRef
33.
Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1989;1(3):1017–26.CrossRef
34.
•• Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446–52 This is a complete view about longitudinal ventricular function in patients with cardiac amyloidosis. CrossRef
35.
• Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Quantitative comparison between amyloid deposition detected by (99m)Tc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis. Circ J. 2016;80(9):1998–2003 This study provides a multiparametric description of the amyloid deposition. CrossRef
36.
• Di Bella G, Minutoli F, Pingitore A, Zito C, Mazzeo A, Aquaro GD, et al. Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy. Circ J. 2011;75(5):1200–8 The review specifies the different motion of epicardial end endocardial layers. CrossRef
37.
Bellavia D, Abraham TP, Pellikka PA, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr. 2007;20(10):1194–202.CrossRef
38.
Belkin RN, Kupersmith AC, Kalique O, et al. A novel two-di- mensional echocardiographic finding in cardiac amyloidosis. Echocardiography. 2010;27:1171–6.CrossRef
39.
•• Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98:1442–8 This is a complete and detailed view about apical sparing in cardiac amyloidosis. CrossRef
40.
Lee GY, Kim HK, Choi JO, Chang SA, Oh JK, Jeon ES, et al. Visual assessment of relative apical sparing pattern is more useful than quantitative assessment for diagnosing cardiac amyloidosis in borderline or mildly increased left ventricular wall thickness. Circ J. 2015;79(7):1575–84.CrossRef
41.
Austin BA, Tang WH, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2:1369e77.CrossRef
42.
Porciani MC, Lilli A, Perfetto F, Cappelli F, Massimiliano Rao C, Del Pace S, et al. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid. 2009;16(2):63–70.CrossRef
43.
• Plehn JF, Huntington M, Skinner M, Cohen A. Valvular regurgitation in primary amyloidosis: an early sign of cardiac involvement (abstr). Clin Res. 1988;36:308A This study explains the valvular involvement in the early stage of amyloidosis.
44.
Plehn J, Dilsizian V, Skinner M, Cohen AS. Ventricular diastolic abnormalities in primary amyloidosis without obvious cardiac involvement (abstr). Circulation. 1986;74(suppl II):II-1800.
45.
Hongo M, Fujii T, Jirayama J, et al. Radionuclide angiographic assessment of left ventricular diastolic filling in amyloid heart disease: a study of patients with familial amyloid polyneuropathy. J Am Coll Cardiol. 1989;13:4853.CrossRef
46.
Plehn JF, Facc, Friedman BJ. Diastolic dysfunction in amyloid heart disease: restrictive cardiomyopathy or not? Editorial Comment JACC. 1989;13(I):6.
47.
Di Bella G, Minutoli F, Madaffari A, Mazzeo A, Russo M, Donato R, et al. Left atrial function in cardiac amyloidosis. J Cardiovasc Med (Hagerstown). 2016;17(2):113–21.CrossRef
Metadata
Title
Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging
Authors
Dalia Di Nunzio
Antonino Recupero
Cesare de Gregorio
Concetta Zito
Scipione Carerj
Gianluca Di Bella
Publication date
01-02-2019
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 2/2019
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-019-1094-z

Other articles of this Issue 2/2019

Current Cardiology Reports 2/2019 Go to the issue

Pericardial Disease (AL Klein and CL Jellis, Section Editors)

Radical Pericardiectomy for Pericardial Diseases

Ischemic Heart Disease (D Mukherjee, Section Editor)

Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients with Diabetes Mellitus: a Treatment-Risk Paradox

Heart Failure (HJ Eisen, Section Editor)

Chagas Cardiomyopathy in Latin America Review

Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Management of Atrial Fibrillation in Patients with Heart Failure: Time to Implement Ablation Control

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits